143
Participants
Start Date
March 31, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
February 29, 2012
Fulvestrant
250 intramuscular injection
Fulvestrant
500 mg intramuscular injection
Research Site, Nagoya
Research Site, Asahi
Research Site, Chiba
Research Site, Matsuyama
Research Site, Fukuoka
Research Site, Kitakyushu
Research Site, Kurume
Research Site, Daito
Research Site, Kōriyama
Research Site, Ōta
Research Site, Fukuyama
Research Site, Hiroshima
Research Site, Kure
Research Site, Sapporo
Research Site, Amagasaki
Research Site, Matsubaracho
Research Site, Isehara
Research Site, Sagamihara
Research Site, Yokohama
Research Site, Kumamoto
Research Site, Sendai
Research Site, Niigata
Research Site, Ōita
Research Site, Kurashiki
Research Site, Izumisano
Research Site, Osaka
Research Site, Sakai
Research Site, Suita
Research Site, Morohongō
Research Site, Shinden
Research Site, Shizuoka
Research Site, Shimotsuke
Research Site, Chūō
Research Site, Koto-ku
Research Site, Kawasaki
Lead Sponsor
AstraZeneca
INDUSTRY